Russia records lowest number of daily Covid-19 cases since early Nov 2020 interfax.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from interfax.com Daily Mail and Mail on Sunday newspapers.
To improve the performance of our website, show the most relevant news products and targeted advertising, we collect technical impersonal information about you, including through the tools of our partners. You can find a detailed description of how we use your data in our Privacy Policy. For a detailed description of the technologies, please see the Cookie and Automatic Logging Policy.
By clicking on the Accept & Close button, you provide your explicit consent to the processing of your data to achieve the above goal.
You can withdraw your consent using the method specified in the Privacy Policy.
Accept & Close
Sputnik International
Russia s EpiVacCorona vaccine has 100% efficacy, says report
Russia s EpiVacCorona vaccine has 100% efficacy, says report
The immunological efficacy of the Russia-developed coronavirus vaccine EpiVacCorona is 100 per cent, the Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being said on Tuesday.
advertisement
UPDATED: January 19, 2021 18:20 IST
EpiVacCorona, Covid-19 vaccine developed in Russia, has 100% immunological efficacy, say reports | representative image from Reuters
The immunological efficacy of the Russia-developed coronavirus vaccine EpiVacCorona is 100 per cent, Sputnik News quoted the Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being as saying.
EpiVacCorona is a coronavirus vaccine developed by the Vektor State Research Center of Virology and Biotechnology in Russia.